Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-03

Clinical Trial Update: Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of BIA 2-093 on the pharmacokinetics of a combined oral contraceptive; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIA 2-093
  • Combined oral contraceptive

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-03